| 13038-5 |
C peptide^30M post XXX challenge |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
C peptide [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
CHAL |
|
13038-5 |
|
|
|
|
Observation |
|
|
|
0 |
C peptide 30M p chal SerPl-mCnc |
|
|
|
Y |
|
30M p chal; After; CHEMISTRY.CHALLENGE TESTING; Connecting peptide of insulin; Level; Mass concentration; p chal; Pept; Pl; Plasma; Plsm; Point in time; Pro-insulin c peptide; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.34 |
1.0j-a |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
| 13039-3 |
C peptide^1H post XXX challenge |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
C peptide [Mass/volume] in Serum or Plasma --1 hour post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
CHAL |
|
13039-3 |
|
|
|
|
Observation |
|
|
|
0 |
C peptide 1h p chal SerPl-mCnc |
|
|
|
Y |
|
1 hour; 1.0Hr; 1h p chal; 60 min; 60 minutes; 60M; 60min; After; CHEMISTRY.CHALLENGE TESTING; Connecting peptide of insulin; Level; Mass concentration; p chal; Pept; Pl; Plasma; Plsm; Point in time; Pro-insulin c peptide; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
1.0j-a |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
| 1304-5 |
D Ab |
Titr |
Ser/Plas |
Pt |
SemiQn |
|
|
ACTIVE |
D Ab [Titer] in Serum or Plasma |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
BLDBK |
|
1304-5 |
|
|
|
|
Observation |
|
|
|
0 |
D Ab Titr SerPl |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; BLOOD BANK; Dextro; Dilution factor; Dilution Factor (Titer); Pl; Plasma; Plsm; Point in time; Random; Rh; Rhesus; SerP; SerPl; SerPlas; Serum; Serum or plasma; SmQn; SR; Titer; Titered; Titre; Ttr |
2.75 |
1 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 13040-1 |
C peptide^1.5H post XXX challenge |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
C peptide [Mass/volume] in Serum or Plasma --1.5 hours post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
CHAL |
|
13040-1 |
|
|
|
|
Observation |
|
|
|
0 |
C peptide 1.5h p chal SerPl-mCnc |
|
|
|
Y |
|
1 1/2 hours; 1 1/2 HR; 1.5h p chal; 1.5Hr; 90 min; 90 minutes; 90M; 90min; After; CHEMISTRY.CHALLENGE TESTING; Connecting peptide of insulin; Level; Mass concentration; p chal; Pept; Pl; Plasma; Plsm; Point in time; Pro-insulin c peptide; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.34 |
1.0j-a |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
| 13041-9 |
C peptide^2H post XXX challenge |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
C peptide [Mass/volume] in Serum or Plasma --2 hours post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
CHAL |
|
13041-9 |
|
|
|
|
Observation |
|
|
|
0 |
C peptide 2h p chal SerPl-mCnc |
|
|
|
Y |
|
120 min; 120 minutes; 120min; 2 hours; 2h p chal; After; CHEMISTRY.CHALLENGE TESTING; Connecting peptide of insulin; Level; Mass concentration; p chal; Pept; Pl; Plasma; Plsm; Point in time; Pro-insulin c peptide; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
1.0j-a |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
| 13042-7 |
C peptide^2.5H post XXX challenge |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
C peptide [Mass/volume] in Serum or Plasma --2.5 hours post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
CHAL |
|
13042-7 |
|
|
|
|
Observation |
|
|
|
0 |
C peptide 2.5h p chal SerPl-mCnc |
|
|
|
Y |
|
2.5h p chal; After; CHEMISTRY.CHALLENGE TESTING; Connecting peptide of insulin; Level; Mass concentration; p chal; Pept; Pl; Plasma; Plsm; Point in time; Pro-insulin c peptide; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.34 |
1.0j-a |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
| 13043-5 |
C peptide^3H post XXX challenge |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
C peptide [Mass/volume] in Serum or Plasma --3 hours post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
CHAL |
|
13043-5 |
|
|
|
|
Observation |
|
|
|
0 |
C peptide 3h p chal SerPl-mCnc |
|
|
|
Y |
|
3h p chal; After; CHEMISTRY.CHALLENGE TESTING; Connecting peptide of insulin; Level; Mass concentration; p chal; Pept; Pl; Plasma; Plsm; Point in time; Pro-insulin c peptide; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
1.0j-a |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
| 13044-3 |
C peptide^5H post XXX challenge |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
C peptide [Mass/volume] in Serum or Plasma --5 hours post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
CHAL |
|
13044-3 |
|
|
|
|
Observation |
|
|
|
0 |
C peptide 5h p chal SerPl-mCnc |
|
|
|
Y |
|
5h p chal; After; CHEMISTRY.CHALLENGE TESTING; Connecting peptide of insulin; Level; Mass concentration; p chal; Pept; Pl; Plasma; Plsm; Point in time; Pro-insulin c peptide; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.34 |
1.0j-a |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
| 13045-0 |
C peptide^6H post XXX challenge |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
C peptide [Mass/volume] in Serum or Plasma --6 hours post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
CHAL |
|
13045-0 |
|
|
|
|
Observation |
|
|
|
0 |
C peptide 6h p chal SerPl-mCnc |
|
|
|
Y |
|
6h p chal; After; CHEMISTRY.CHALLENGE TESTING; Connecting peptide of insulin; Level; Mass concentration; p chal; Pept; Pl; Plasma; Plsm; Point in time; Pro-insulin c peptide; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.34 |
1.0j-a |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
| 13046-8 |
Lymphocytes.variant/Leukocytes |
NFr |
Bld |
Pt |
Qn |
|
|
ACTIVE |
Variant lymphocytes/Leukocytes in Blood |
|
NAM |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
HEM/BC |
|
13046-8 |
|
|
|
|
Observation |
|
|
|
0 |
Variant Lymphs NFr Bld |
|
|
|
Y |
|
Atypical lymphocytes; Blood; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Lymp; Lymph; Lympho; Lymphocyte; Lymphs; Lymphs%; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Reactive lymphocytes; Variant lymphocytes; Variant Lymphs; WB; WBC; WBCs; White blood cell; White blood cells; Whole blood |
2.79 |
1.0j-a |
|
|
|
|
|
|
|
% |
|
|
Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; |
0 |
| 13047-6 |
Plasma cells/Leukocytes |
NFr |
Bld |
Pt |
Qn |
|
|
ACTIVE |
Plasma cells/Leukocytes in Blood |
|
NAM |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
HEM/BC |
|
13047-6 |
|
|
|
|
Observation |
|
|
|
0 |
Plasma Cells NFr Bld |
|
|
|
Y |
|
Blood; Cell; Cellularity; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Myeloma cells; Number fraction; Percent; Plasmacyte; Plasmacytes; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; WBC; WBCs; White blood cell; White blood cells; Whole blood |
2.79 |
1.0j-a |
|
|
|
|
|
|
|
% |
|
|
Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; |
0 |
| 13048-4 |
Sezary cells |
PrThr |
Bld |
Pt |
Ord |
Microscopy.light |
|
ACTIVE |
Sezary cells [Presence] in Blood by Light microscopy |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HEM/BC |
|
13048-4 |
|
Microscopy.light |
|
|
Observation |
|
|
|
0 |
Sezary Cells Bld Ql Smear |
|
|
|
|
|
Blood; Cell; Cellularity; HEMATOLOGY/CELL COUNTS; LM; Lutzner cells; Micro; Micros; Microscopic; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; WB; Whole blood |
2.56 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 13049-2 |
von Willebrand factor Ag |
ACnc |
PPP |
Pt |
Qn |
Imm |
|
DEPRECATED |
Deprecated von Willebrand factor (vWf) Ag [Units/volume] in Platelet poor plasma by Immunologic method |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
COAG |
|
13049-2 |
|
Imm |
|
|
|
|
|
|
0 |
Deprecated vWF:Ag PPP Imm-aCnc |
|
|
|
|
|
Antigen; Antigens; Arbitrary concentration; COAGULATION; Fac; Fact; Hematology; Heme; Immunol; Immunology; Immunology?; Plas; Platelet poor plasma; Point in time; QNT; Quan; Quant; Quantitative; Random; Von will; Vonwillebrand; vWf; vWF:Ag |
2.69 |
1.0j-a |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
| 1305-2 |
D Ag |
PrThr |
Bld |
Pt |
Ord |
|
|
ACTIVE |
D Ag [Presence] in Blood |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
BLDBK |
|
1305-2 |
|
|
|
|
Observation |
|
|
|
0 |
D Ag Bld Ql |
|
|
|
|
|
Antigen; Antigens; Blood; BLOOD BANK; Dextro; Hematology; Heme; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Rh; Rhesus; Screen; WB; Whole blood |
2.73 |
1 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 13050-0 |
Protein C/Coagulation factor IX |
MRto |
PPP |
Pt |
Qn |
|
|
ACTIVE |
Protein C/Coagulation factor IX [Mass Ratio] in Platelet poor plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
COAG |
|
13050-0 |
|
|
|
|
Both |
|
|
|
0 |
Prot C/Fact IX PPP |
|
|
|
Y |
|
Antihemophilic factor B; Autoprothrombin II-a; Christmas factor; Coag; Fac; Fact; Fact IX; Factor 9; FIX; Hematology; Heme; Mass concentration ratio; Mass ratio; MCRto; PC; Plas; Plasma thromboplastin component; Platelet poor plasma; Point in time; PR; Prot; Prot C; PTC; QNT; Quan; Quant; Quantitative; Random; Thrombocyte cofactor II |
2.42 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 13051-8 |
Protein S |
ACnc |
PPP |
Pt |
Qn |
|
|
DEPRECATED |
Deprecated Protein S [Units/volume] in Platelet poor plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
COAG |
|
13051-8 |
|
|
|
|
Both |
|
|
|
0 |
Deprecated Prot S PPP-aCnc |
|
|
|
Y |
|
Arbitrary concentration; COAGULATION; Hematology; Heme; Plas; Platelet poor plasma; Point in time; PR; Prot; Prot S; PS; QNT; Quan; Quant; Quantitative; Random; S prime |
2.69 |
1.0j-a |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
| 13052-6 |
Protein S/Coagulation factor IX |
MRto |
PPP |
Pt |
Qn |
Coag |
|
ACTIVE |
Protein S/Coagulation factor IX [Mass Ratio] in Platelet poor plasma by Coagulation assay |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
COAG |
|
13052-6 |
|
Coag |
|
|
Both |
|
|
|
0 |
Prot S/Fact IX PPP |
|
|
|
Y |
|
Antihemophilic factor B; Christmas factor; Clot; Clottable; Coag; Coagulation assay; Fac; Fact; Fact IX; Factor 9; FIX; Hematology; Heme; Mass concentration ratio; Mass ratio; MCRto; Plas; Plasma thromboplastin component; Platelet poor plasma; Point in time; PR; Prot; Prot S; PS; PTC; QNT; Quan; Quant; Quantitative; Random; S prime; Thrombocyte cofactor II; Tilt tube |
2.42 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 13053-4 |
Coagulation kaolin induced |
ACnc |
PPP |
Pt |
Qn |
|
|
ACTIVE |
Kaolin activated time [Units/volume] in Platelet poor plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
COAG |
|
13053-4 |
|
|
|
|
Both |
|
|
|
0 |
KCT PPP-aCnc |
|
|
|
Y |
|
Arbitrary concentration; Coag; Hematology; Heme; Kaolin Activated Time; Kaolin Clotting Time; KCT; Plas; Platelet poor plasma; Point in time; QNT; Quan; Quant; Quantitative; Random |
2.73 |
1.0j-a |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
|
0 |
| 13054-2 |
Fibrin+Fibrinogen fragments |
ACnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Fibrin+Fibrinogen fragments [Units/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
COAG |
|
13054-2 |
|
|
|
|
Both |
|
|
|
0 |
FSP Ur-aCnc |
|
|
|
Y |
|
Arbitrary concentration; COAGULATION; Coagulation factor I; FDP; FgDP; FGN; Fibrin degradation products; Fibrin split products; Fibrinogen degradation products; Fibrinogen Frg; Fibrinogen related antigens; Frag; Fragment; FSP; Hematology; Heme; Point in time; QNT; Quan; Quant; Quantitative; Random; TDP; UA; UR; Urn |
2.73 |
1.0j-a |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
|
0 |
| 13055-9 |
Heparin |
ACnc |
PPP |
Pt |
Qn |
|
|
DISCOURAGED |
Heparin [Units/volume] in Platelet poor plasma |
|
MIN |
DefinitionDescription |
|
|
arb U/mL |
|
|
|
|
|
|
COAG |
|
13055-9 |
|
|
|
|
Both |
|
|
|
0 |
Heparin PPP-aCnc |
|
|
|
Y |
|
Arbitrary concentration; COAGULATION; Hematology; Heme; Hep; Hepar; Heparn; Plas; Platelet poor plasma; Point in time; QNT; Quan; Quant; Quantitative; Random |
2.73 |
1.0j-a |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
| 13056-7 |
Platelets |
NCnc |
Plas |
Pt |
Qn |
Automated count |
|
ACTIVE |
Platelets [#/volume] in Plasma by Automated count |
|
MIN |
DefinitionDescription |
|
|
10*3/uL |
|
|
|
|
|
|
HEM/BC |
|
13056-7 |
|
Automated count |
|
|
Both |
|
|
|
0 |
Platelet # Plas Auto |
|
|
|
Y |
|
#; ABS; absolute; absolutes; Auto; Automated detection; Cnt; Count; Count/volume; CT; Elec; Elect; Electr; HEMATOLOGY/CELL COUNTS; Number concentration; Number Concentration (count/vol); Pl; Plasma; Platelet; Platelet count; Platelt; Plsm; Plt; Point in time; QNT; Quan; Quant; Quantitative; Random; Thrb; Thrombocyte; Thrombocytes |
2.73 |
1.0j-a |
|
|
|
|
|
|
|
10*3/uL |
|
|
|
0 |
| 13057-5 |
Platelets |
ACnc |
Dial fld |
Pt |
Qn |
|
|
ACTIVE |
Platelets [Units/volume] in Dialysis fluid |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HEM/BC |
|
13057-5 |
|
|
|
|
Observation |
|
|
|
0 |
Platelet Dial fld-aCnc |
|
|
|
Y |
|
Arbitrary concentration; Diaf; Dialysate; Dialysis fluid; HEMATOLOGY/CELL COUNTS; Platelet; Platelt; Plt; Point in time; QNT; Quan; Quant; Quantitative; Random; Thrb; Thrombocyte; Thrombocytes |
2.69 |
1.0j-a |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
|
0 |
| 13058-3 |
Coagulation surface induced^2nd specimen |
Time |
PPP |
Pt |
Qn |
Coag |
|
ACTIVE |
aPTT in Platelet poor plasma by Coagulation assay --2nd specimen |
|
MIN |
DefinitionDescription |
|
|
s |
|
|
|
|
|
|
COAG |
|
13058-3 |
|
Coag |
|
|
Observation |
|
|
|
0 |
aPTT sp2 PPP |
|
|
|
Y |
|
Activated partial thromboplastin time; aPTT; Clot; Clottable; Coag; Coagulation assay; Convalescent; Hematology; Heme; Little(A)PTT; Partial Thromboplastin Time; Plas; Platelet poor plasma; Point in time; Post immunization; PTT; QNT; Quan; Quant; Quantitative; Random; Second; sp2; Spec; Surf; Tilt tube |
2.73 |
1.0j-a |
|
|
|
|
|
|
|
s |
|
|
|
0 |
| 13059-1 |
Coagulation surface induced^3rd specimen |
Time |
PPP |
Pt |
Qn |
Coag |
|
ACTIVE |
aPTT in Platelet poor plasma by Coagulation assay --3rd specimen |
|
MIN |
DefinitionDescription |
|
|
s |
|
|
|
|
|
|
COAG |
|
13059-1 |
|
Coag |
|
|
Observation |
|
|
|
0 |
aPTT sp3 PPP |
|
|
|
Y |
|
Activated partial thromboplastin time; aPTT; Clot; Clottable; Coag; Coagulation assay; Hematology; Heme; Little(A)PTT; Partial Thromboplastin Time; Plas; Platelet poor plasma; Point in time; PTT; QNT; Quan; Quant; Quantitative; Random; sp3; Spec; Surf; Tilt tube |
2.52 |
1.0j-a |
|
|
|
|
|
|
|
s |
|
|
|
0 |
| 1306-0 |
D NOS Ab |
PrThr |
Ser/Plas |
Pt |
Ord |
|
|
DEPRECATED |
Deprecated D NOS Ab [Presence] in Serum or Plasma |
|
DEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
BLDBK |
|
1306-0 |
|
|
|
|
Observation |
|
|
|
0 |
Deprecated D NOS Ab SerPl Ql |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; BLOOD BANK; Dextro; Ordinal; Other; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.65 |
1 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
